Hillman Cancer Center at University of Pittsburgh Cancer Institute is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Hillman Cancer Center at University of Pittsburgh Cancer Institute has participated in 52 clinical trials.
Therapeutic areas: Breast Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer.
Sponsors: University of Wisconsin, Madison, National Cancer Institute (NCI), Eastern Cooperative Oncology Group.
Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Hillman Cancer Center at University of Pittsburgh Cancer Institute has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Hillman Cancer Center at University of Pittsburgh Cancer Institute has 52 clinical trials on record. Their work covers Breast Cancer, Chronic Myeloproliferative Disorders, Colorectal Cancer.
Yes — Hillman Cancer Center at University of Pittsburgh Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.